The "no-reflow" phenomenon, the occurrence of areas with very low flow in hearts reperfused after ischemia, is thought to be largely established at the time of reperfusion as a result of microvascular damage induced by ischemia. In the present study we sought to determine whether additional impairment of tissue perfusion might also occur during the course of reperfusion. Open-chest dogs were subjected to 90 minutes of left circumflex coronary artery occlusion and reperfused for 2 minutes (n=7) or 3.5 hours (n=8). Myocardial perfusion was visualized in left ventricular slices following in vivo injection of the fluorescent dye thioflavin-S just before killing. The area of impaired perfusion (absent thioflavin) averaged 9.5+3.0% of the risk region in dogs reperfused for 2 minutes, whereas it was nearly three times as large in dogs reperfused for 3.5 hours (25.9 ±8.2% of the risk region, p<0.05). Serial measurements of flow by microspheres during reperfusion demonstrated zones within the postischemic myocardium that were hyperemic 2 minutes after reperfusion, with adequate flow still present at 30 minutes, but with a subsequent marked fall in perfusion. After 3.5 hours these areas showed negligible flow (0.13 ±0.03 ml/min/g) and no thioflavin uptake. Tissue samples showving postischemic impairment in perfusion had received virtually no collateral flow during ischemia (<0.01 mlUmin/g), whereas collateral flow was significantly higher in adjacent thioflavin-positive zones (0.04±0.01 ml/min/g in endocardial samples and 0.07±0.02 ml/min/g in samples from the midmyocardium, p<0.001 vs. thioflavin-negative areas). Areas that showed late impairment of flow invariably demonstrated contraction band necrosis, which contrasted with the pattern of coagulation necrosis observed in areas of "true" (i.e., immediate) no-reflow. Intracapillary erythrocyte stasis and marked intravascular neutrophil accumulation (to levels >20-fold that found after 2 minutes reperfusion) were typically observed in areas of delayed impairment to flow. Obstruction to flow at the capillary level was confirmed in additional dogs in which the heart was injected postmortem with silicone rubber to delineate the microvascular filling pattern. Areas of absent capillary filling were much more extensive after 3.5 hours than after 2 minutes reperfusion. Thus, this study shows that the occurrence of areas of markedly impaired perfusion in postischemic myocardium is related only in part to an inability to reperfuse certain areas on reflow. A more important factor is represented by a delayed, progressive fall in flow to areas that initially received adequate reperfusion. This phenomenon develops in regions receiving no collateral flow during ischemia and is associated with neutrophil accumulation and capillary plugging late during the course of reperfusion. (Circulation
R estoration of the blood supply to previously ischemic tissue is not always followed by uniform return of perfusion to the microvasculature. In 1968, Ames et all studied cerebral ischemia in the rabbit and reported the occurrence of areas that lacked vascular filling on reperfusion. The authors suggested that microvascular compression from ischemia-induced tissue edema was responsible for an inability of the tissue to reperfuse; hence, the term "no-reflow." The occurrence of the no-reflow phenomenon in the heart was first noted by Krug et al,2 and important pathologic observations were made by Kloner et al3 in a canine model. In Kloner's study, after coronary artery occlusion for 90 minutes and reperfusion for times ranging from 10 seconds to 20 minutes, portions of the previously ischemic area failed to stain with the fluorescent dye thioflavin-S that was given in vivo as a perfusion marker. In the poorly perfused areas (absent thioflavin), severe capillary damage and coagulation necrosis were observed. Contraction bands were absent, consistent with the notion that these areas had not received significant reflow despite release of the coronary artery ligature. These findings lent further support to the hypothesis that no reflow is the consequence of severe damage to the microvasculature caused by ischemia and that it is largely established at the moment of reperfusion. [3] [4] [5] However, recent evidence suggests that in the heart as well as other tissues, reperfusion can induce injury over and above the damage caused by ischemia.6 It is possible, therefore, that microvascular damage might also develop during reperfusion, either secondary to myocyte damage or by means of direct vascular injury. and/or platelet'1 adherence to the endothelium, as well as direct free radical attack,'2 have been proposed as possible causes of vascular damage in reperfused tissues. If widespread vascular obstruction occurred during the reperfusion phase as a consequence of these or other mechanisms, the mass of myocardium receiving little or no flow should increase progressively over time after reperfusion. Despite the wealth of data on myocardial consequences of reperfusion, little is known about the consequences of postischemic reflow on microvascular integrity or about its effects on tissue perfusion.
In the present study, we sought to determine whether progressive damage to the microvasculature occurs in dog hearts during postischemic reperfusion. For this purpose we compared the size of the area of myocardium showing low flow immediately after reperfusion ("true" no-reflow) with the size of the low flow zone delineated several hours after reflow (delayed impairment to flow). The ultrastructural features of myocardium within areas of immediate and delayed impairment to flow, as well as of postischemic but normally perfused tissue, were also analyzed. Finally, we measured serial changes in regional blood flow in tissue samples from the previously ischemic region to look for evidence of progressive vascular obstruction.
Methods

Surgical Preparation
Mongrel dogs of either sex (20-25 kg) were anesthetized with i.v. sodium thiamylal (18 mg/kg), followed by i.m. a-chloralose (14 mg/kg) and urethane (136 mg/kg), and ventilated with room air. Polyethylene catheters were placed in the right femoral artery and vein, a left thoracotomy was performed, and a catheter was placed in the left atrium. An electromagnetic flowmeter and a pneumatic occluder were placed around the circumflex coronary artery proximal to any major marginal branch. Heart rate, circumflex coronary artery blood flow, and arterial and left atrial pressures were continuously monitored.
Experimental Protocol
After baseline measurements of regional myocardial blood flow (see below), the occluder was inflated. The flowmeter signal was used to verify complete coronary occlusion. Regional myocardial blood flow was measured again 85 minutes after occlusion. After 90 minutes of occlusion, blood flow was restored by deflation of the occluder. Dogs were assigned to two groups. The animals in the first group (n=8) were reperfused for 3.5 hours; regional myocardial blood flow was measured at the time of peak reactive hyperemia (about 2 minutes after the onset of reperfusion) and again after 30 minutes and 3.5 hours of reperfusion. In the second group (n=7), the dogs were reperfused only long enough to obtain the first regional myocardial blood flow measurement at peak reactive hyperemia. All dogs survived until completion of their respective protocols. One animal in each group developed ventricular fibrillation during ischemia and was resuscitated. After excision the heart was placed in ice-cold saline containing 20 mM KCl. The right ventricle and the atria were removed, and the left ventricle was cut into six to eight slices parallel to the To determine the extent of myocardial necrosis in the 3.5 -hour reperfusion group, the left ventricular slices were incubated at 370 C in triphenyltetrazolium chloride (TTC) for 30 minutes. The slices were photographed in color, and the transparencies were projected onto a sheet of paper. The outlines of the slice, risk region, and TTC-negative (necrotic) area were traced, and the size of the risk region and infarct were calculated by planimetry. Infarct size was not measured in one dog.
Measurement of Regional Myocardial Blood Flow
Regional myocardial blood flow was measured with 16 ,um diameter radioactive microspheres (NEN-TRAC, New England Nuclear, Boston, Massachusetts). For each flow measurement 4,000,000 microspheres labeled with 14lCe tt3Sn, 103Ru, 95Nb, or 46Sc were injected into the left atrium. Starting before injection and continuing for 2 minutes afterwards, a reference arterial blood sample was withdrawn by a Harvard pump at a constant rate of 2.16 ml/min. For assessment of average regional myocardial blood flow, sampling (1-2 g) was done transmurally in the center of the risk region and in the nonischemic anterior wall for each left ventricular slice. Samples were divided into inner and outer halves, weighed, and counted for radioactivity with the reference blood samples at appropriate energy windows. Myocardial blood flow (ml/min/g) was calculated by standard methods13 and corrected to account for the combined effects of microsphere loss, local edema, and hemorrhage. rings from apex to base, and 1-cm3 blocks were cut from normal and postischemic regions. The blocks were cleared by a process that changes tissue into a semitranslucent amber material through which the microfil-filled microvasculature could be viewed. Samples were sequentially placed for 24 hours in each of the following solutions: tap water, distilled water, 70% ethanol, 80% ethanol, 95% ethanol, 100% ethanol, and a solution of 3 parts benzyl benzoate to 4 parts methyl benzoate. Samples were then cut into 1-2 mm thick slices, stored in the final clearing solution, and viewed stereoscopically and photographed at different magnifications under a dissecting microscope using epi-illumination.
Statistical Analysis
Data are presented as the mean±SEM. Differences in the various groups were tested by Student's t test for unpaired samples or repeatedmeasures analysis of variance (ANOVA), as appropriate.
Results
Validation of Thioflavin-S as Flow Marker
After injection of thioflavin-S, the myocardium in the nonischemic anterior wall was characterized by relatively uniform fluorescence under ultraviolet light (thioflavin-positive, Figure 1 ). In contrast, in the previously ischemic risk region thioflavin-negative (i.e., nonfluorescent) zones were observed in the inner layers ( Figure 1 ). Lack of thioflavin staining was associated with low blood flow. At the time of dye injection, flow in samples taken from thioflavinnegative areas (n=41) averaged 0.13±0.03 ml/min/g tissue in dogs reperfused for 3.5 hours, whereas tissue specimens taken from within the risk region but from the thioflavin-positive areas in the same animals (n=62) showed normal flow (1.18±0.16 ml/min/g). Half of the thioflavin-negative samples had negligible or no flow (<0.05 ml/min/g), and 73% showed flow values lower than 0.2 ml/min/g (Figure 2 , upper panel). There was little overlap of flow values between thioflavinnegative and positive areas with a cutoff point around 0.4 ml/min/g (Figure 2 , lower panel). Flow in thioflavinnegative areas in dogs sacrificed early after reflow was also low, averaging 0.26±0.04 ml/min/g. Despite the injection of thioflavin-S during hyperemia in these animals, the distribution of flow in thioflavin-negative and positive areas was similar to the 3.5 hour reperfusion group. Flow was lower than 0.4 ml/min/g in 80% of thioflavin-negative samples, whereas in 98% of tissue specimens from thioflavin-positive areas, flow was more than 0.4 ml/min/g, with an average of 2.79±0.25 ml/min/g. Extent ofArea of Impaired Perfusion, Risk Region, and Area of Necrosis Proximal circumflex occlusion resulted in similar hemodynamic changes in the two groups ( Table 2 ). The size of risk regions was also similar in the two groups ( Figure 3 ). In dogs sacrificed early after reperfusion, the flow-impaired thioflavin-negative ("true no-reflow") area was confined to the subendocardium and averaged 9.5 +3.0% of the risk region ( Figure 3 ). However, in dogs reperfused for 3.5 hours, the thioflavin-negative zone encompassed most of the subendocardium and often extended into the midmyocardium, representing 25.9+8.2% of the risk region (p<0.05, Figure 3 ). In the 3.5-hour reperfusion group infarct size averaged 41.4+7.5% of the risk region. In this group, the zone of impaired perfusion was always contained within the area of myocardial necrosis delineated by 1TC staining. The sizes of the infarct and low flow areas were linearly correlated (y=0.85x+ 19.5; r2=0.86), with a minimum infarct size of about 20% of the risk region required before any low flow area was seen.
Regional Myocardial Blood Flow
The severity of ischemia, as assessed from collateral blood flow to the center of the risk region, was almost identical in the two groups of dogs (Table 3) . On reperfusion average flow in both inner and outer layers increased about twofold over preischemic values. This hyperemic response subsided between 30 and 210 minutes of reperfusion (Table 3) .
In addition to these measurements of average flow to the risk region, we analyzed flow changes during 3.5 hours of reperfusion in tissue specimens Figure 4 , lower panel). A similar difference in collateral flow between thioflavin-positive and negative zones was observed in dogs from the short reperfusion group (Table 4) . Tissue specimens from areas showing no thioflavin uptake 3.5 hours after reperfusion exhibited a hyperemic response early after reperfusion (Figure 4 , upper panel). Distribution analysis of flow in these samples showed that 2 minutes after reflow, the majority of samples taken from thioflavin-negative zones were being perfused at a flow rate more than 1 ml/min/g, whereas only 10% of the samples had a flow of 0.4 ml/min/g or less ( Figure 5 ). Since lack of thioflavin staining was associated in our study with flows lower than 0.4 ml/min/g (Figure 2 ), these results suggest that most of the specimens sampled from thioflavin-negative areas 3.5 hours after reperfusion would have actually belonged to the thioflavinpositive zone if delineated early after reflow. Furthermore, flow in these specimens was still relatively high 30 minutes after reperfusion (Figure 4, upper  panel) . On the other hand, samples from thioflavinpositive areas at 3.5 hours of reperfusion, even though within the infarcted zone, showed higher levels of early reflow, and although flow decreased during the remainder of the study, it did not fall below baseline levels (Figure 4, lower panel) . 
THIOFLAVIN-S NEGATIVE SAMPLES
Ultrastructural Observations
Specimens from thioflavin-negative areas from both groups of dogs showed widespread tissue damage. No zones of normal or only mildly injured myocardium were seen within the thioflavinnegative area in either group. Areas of no-reflow in dogs reperfused for 2 minutes were characterized by coagulation necrosis with relaxed myofibrils, cellular edema, swollen mitochondria with fractured cristae, and nuclear changes ( Figure 6A and B). These features accounted for more than 95% of the total tissue area analyzed ( Table 5 ). The vascular endothelium demonstrated severe injury with edema, cytoplasmic clearing, loss of pinocytotic vesicles, nuclear changes, and formation of blebs and membrane bound bodies protruding into the vascular lumen ( Figure 6B ). The mean endothelial cell injury score was 2.5+±0.2.
In striking contrast with the pattern observed after 2 minutes of reflow, thioflavin-negative areas from dogs reperfused for 3.5 hours mostly showed contraction band necrosis, involving more than 95% of the total area analyzed (p<0.001 vs. 2 minute dogs). The usual picture was that of severe tissue injury with hypercontracted sarcomeres and swollen mitochondria with disrupted cristae and calcium precipitates ( Figure 6C and D, Table 5 ). Endothelial damage was always prominent (mean injury score, 2.3+0.2). Figure 6C and D).
Microvascular Injection Studies
Postmortem injection of the coronary arteries with microfil confirmed that in the hearts made ischemic for 90 minutes and reperfused for only 2 minutes, the microvasculature was largely patent with filling of the majority of capillaries throughout the left ventricular wall. Lack of capillary filling was noted in a small rim of endocardium. Small focal areas of capillary nonfilling were also visualized in the inner layers of the postischemic region ( Figure  8B and C). In the two hearts reperfused for 3.5 hours, the picture was dramatically different (Figure 8D and E) . Large confluent areas of capillary nonfilling were seen. Filling was seen down to the arteriolar level with frequent, abrupt truncation of the microfil column in the visualized arterioles ( Figure 8E ). In the one heart in which retrograde microfil injection was performed, a large confluent zone was seen with capillary nonfilling and apparent blockade at the venular level ( Figure 8F ).
Discussion
Restoration of blood flow in a previously occluded coronary artery is not always followed by the return of normal tissue perfusion. The ability to reperfuse certain areas of ischemic myocardium has traditionally been considered to be a consequence of microvascular damage occurring during ischemia and, therefore, to represent a process already established at the beginning of arterial reflow (hence, the term "'no-reflow"')." 3, 1516 In the present study, however, the area of impaired perfusion delineated by thioflavin-S was about three times larger after 3.5 hours than after 2 minutes reperfusion. Furthermore, direct measurements of blood flow showed that myocardium with poor perfusion at 3.5 hours received, for the most part, substantial reperfusion initially, followed by a marked decline in flow over time. These findings demonstrate that in addition to the area of "true" (i.e., immediate) no-reflow found at the time of reperfusion, a substantial portion of postischemic myocardium undergoes progressive vascular obstruction during reperfusion. These areas of delayed impairment to flow were also characterized by distinctive morphologic features.
Previous studies have measured serial changes in blood flow in postischemic myocardium but failed to observe this progressive decrease in flow. [17] [18] [19] However, without a specific attempt to delineate spatially the areas of low flow, specimens from postischemic myocardium generally contain mixtures of low flow and normally perfused or hyperemic tissue. A marked fall in flow to a portion of the sample could go unnoticed because of high flow in the remainder. Cobb et a120 showed that after 2 hours coronary artery occlusion in the dog, flow remained at near-normal levels in the majority of tissue specimens during 4 hours of reperfusion. However, a marked decrease in flow was found during reperfusion in the lowest flow samples showing extensive necrosis at the end of the study. Because the area of low flow was not spatially delineated in Cobb et al's study, an increase in the amount of poorly perfused myocardium during reperfusion could not be detected.
In a previous study Kloner et a13 found no differences in the extent of no-reflow after reperfusion periods ranging from 10-12 seconds to 20 minutes. Severe capillary damage with coagulation necrosis was the usual morphologic pattern observed in areas of no-reflow while contraction bands were absent. Our data are in partial agreement with those of Kloner et al because we also found areas of immediate no-reflow early after reperfusion, characterized by myocyte coagulation necrosis with edema but without contraction bands. However, in addition to these findings, we observed progressive impairment to flow in tissue that was initially reperfused. The typical ultrastructural pattern of such tissue was that of endothelial damage in the presence of contraction band necrosis. An In our study, underperfused areas were not uniformly distributed. Although confined to the subendocardium and midmyocardium, thioflavin-negative areas were often spatially separated by areas of myocardium with much better perfusion. This phenomenon was particularly evident in hearts examined early after reflow. Our data suggest that the basis for this heterogeneity of tissue perfusion was a corresponding heterogeneity of the degree of ischemia. Thioflavin-negative areas received virtually no flow during the period of occlusion, whereas immediately adjacent, thioflavin-positive areas located within the ischemic zone were exposed to significantly higher (although still quite low) collateral flow. Impaired reperfusion in areas exposed to low collateral flow might suggest that a particularly severe ischemic insult may have been necessary to damage the microvasculature. Alternatively, very low levels of flow may have been required to "lprime" the myocardium for subsequent reperfusion injury. [29] [30] [31] In the setting of severe ischemia, a number of processes may occur that can promote oxygen radical formation during reperfusion, including an increase of hypoxanthine and xanthine,32 conversion of xanthine dehydrogenase to its oxidase form,33 loss of scavenging enzymes,34 and accumulation of granulocytes. 35 The basis for the focal heterogeneity of ischemia during coronary occlusion is unknown. Flow in certain vessels might cease because of random obstruction by blood elements and/or local increase in extravascular compressive forces. Another possibility relates to the anatomy of the vasculature. Certain branching angles or the number of vascular divisions occurring before a given precapillary vessel is reached may determine the pressure drop along its length and thereby influence blood flow. These factors might also make certain areas of myocardium more susceptible to a progressive increase in coronary resistance, which may occur during ischemia. [36] [37] [38] Granulocytes have recently been proposed as a major factor in the no-reflow phenomenon. Studies by Engler et a18-10 have shown that leukocytes can be seen in individual capillaries from postischemic myocardium with red blood cells apparently piled up behind, suggesting mechanical obstruction. Reperfusion greatly enhances accumulation of neutrophils in the postischemic myocardium in a timedependent fashion,79'39 presumably secondary to enhanced adhesion of white cells to the capillary endothelium. 40 42 The hypothesis that leukocytes can cause microvascular obstruction is supported by the observation that depletion of leukocytes or administration of agents that interfere with neutrophil function reduces granulocyte and red cell accumulation30'42'43 and results in less "no-reflow. '8"44 In our study neutrophil accumulation was much more pronounced in those areas of myocardium undergoing delayed impairment of blood flow. Plugging of the capillaries by neutrophils could have caused vascular erythrocyte packing upstream from the point of obstruction and prevented the penetration of microfil beyond the arteriolar level. Our finding of greater erythrocyte accumulation in areas of delayed flow impairment is also consistent with the possibility of capillary plugging by neutrophils as well as with the notion that the extent of myocardial hemorrhage in reperfused hearts depends on the severity of the ischemic insult.5 '45 Our data suggest that in addition to vascular damage, progressive myocyte damage might have occurred during reperfusion. Of the tissue area analyzed from the thioflavin-positive zone immediately after reflow, 13% was morphologically normal and an additional 30% showed only mild ischemic changes consistent with reversible injury. In addition, endothelial damage was absent or mild. Because the area of impaired perfusion increased threefold over 3.5 hours, we can speculate that some of the tissue that was thioflavin-positive immediately after reflow may have been subsequently converted to thioflavinnegative areas with extensive contraction band necrosis and severe endothelial injury. These observations are consistent with the hypothesis that reperfusion may induce specific damage to nonirreversibly injured myocardium and vascular endothelium as a result of oxygen radical formation and/or granulocyte activation.6,27,35 While several investigators failed to demonstrate significant tissue preservation from "anti-free radical" interventions,46 48 A major question is whether vascular obstruction during reperfusion may directly contribute to myocyte damage. The available evidence would suggest that at least for "immediate" no-reflow, the die is cast, and the surrounding myocytes are already dead at the moment of reperfusion. Kloner et a153 have emphasized that during myocardial ischemia ultrastructural features of myocyte injury appear to precede microvascular injury and that the area of no-reflow is always contained within the border of myocardial necrosis, suggesting that no-reflow occurs because of myocyte death and not vice versa. However, the situation is less clear for "delayed" no-reflow. Although we observed that the no-reflow area was also contained within the infarcted area after 3.5 hours reperfusion, progressive vascular obstruction in principle could have led to an extension of necrosis, perhaps by converting areas of patchy necrosis to confluent necrosis. Interestingly, in previous studies prevention of reperfusion injury resulted in a patchy distribution of myocardial necrosis, whereas the infarcted region appeared largely confluent in control animals. 29-49-52 On the basis of our data, no firm conclusion can be reached as to the existence of a causal relation between progressive damage to the microvasculature and extension of myocyte damage. However, it can be speculated that both phenomena might occur at the same time through a common mechanism. Vascular and myocyte injury could both result at reperfusion from generation of oxygen radicals from several sources, including the xanthine oxidase reaction (occurring mainly in endothelial cells) and granulocytes that have adhered to the endothelial surface. Intraluminally produced free radicals could diffuse into the interstitial space to attack myocytes.54,55 After the initial damage, additional granulocyte adhesion might occur, leading to further myocyte and vascular injury and further granulocyte accumulation and microvascular obstruction. In addition, activated neutrophils may release vasoconstricting substances, which could contribute to progressive impairment of flow. 56 Thus, "delayed no-reflow"might signify a vicious cycle of reperfusion-induced vascular and myocyte injury, initiated by a sufficient degree of ischemic injury to "prime" the reaction and resulting in progressive tissue necrosis.
Preservation of tissue perfusion might have beneficial effects other than prevention of cell necrosis. 57 The delivery of drugs to the previously ischemic myocardium should be enhanced, as well as the capacity to develop collateral vessels between the postischemic region and adjacent vascular territories. Furthermore, infarct expansion and formation of left ventricular aneurysms might be prevented through an alteration of tissue mechanical properties or promotion of infarct healing. Interestingly, recent studies have demonstrated that late postischemic reperfusion reduces infarct expansion in the rat without altering infarct size. 58, 59 Thus, while it is unclear whether prevention of "delayed no-reflow" will translate into infarct size reduction in reperfused hearts, it is likely that preservation of tissue perfusion will have a number of other favorable consequences.
